- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
Market Overview
The COVID-19 Molecular Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global COVID-19 Molecular Diagnostics sales will be xx in 2020 from COVID-19 Molecular Diagnostics million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global COVID-19 Molecular Diagnostics market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the COVID-19 Molecular Diagnostics industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on COVID-19 Molecular Diagnostics and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
COVID-19 Molecular Diagnostics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, COVID-19 Molecular Diagnostics market has been segmented into:
High-throughput Sequencing
Nucleic Acid Detection Based on Real-time Fluorescent Quantitative PCR
Immunological Detection
By Application, COVID-19 Molecular Diagnostics has been segmented into:
Hospitals
Scientific Research
Biodiagnostics
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global COVID-19 Molecular Diagnostics market presented in the report. This section sheds light on the sales growth of different regional and country-level COVID-19 Molecular Diagnostics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global COVID-19 Molecular Diagnostics market.
The report offers in-depth assessment of the growth and other aspects of the COVID-19 Molecular Diagnostics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and COVID-19 Molecular Diagnostics Market Share Analysis
COVID-19 Molecular Diagnostics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, COVID-19 Molecular Diagnostics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the COVID-19 Molecular Diagnostics sales, revenue and market share for each player covered in this report.
The major players covered in COVID-19 Molecular Diagnostics are:
Cellex
Thermo Fisher
BioMedomics
Abbott
Safecare Bio-Tech
Roche
Agilent
Henry Schein
BD
Bio-rad
Guangdong Hecin-Scientific
Mayo Clinic Laboratories
Ortho Clinical Diagnostics
Mount Sinai Laboratory
Dynamiker Biotechnology (Tianjin)
Guangzhou Wondfo Biotech
Zhejiang Orient Gene Biotech
Chembio Diagnostics
ADVAITE
Innovita Biological Technology
Da An Gene
QIAGEN
Techne
Analytik Jena
Shanghai ZJ Bio-Tech
Esco
Bioer
BGI
Biosynex
Among other players domestic and global, COVID-19 Molecular Diagnostics market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 COVID-19 Molecular Diagnostics Market Overview
1.1 Product Overview and Scope of COVID-19 Molecular Diagnostics
1.2 Classification of COVID-19 Molecular Diagnostics by Type
1.2.1 Global COVID-19 Molecular Diagnostics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global COVID-19 Molecular Diagnostics Revenue Market Share by Type in 2019
1.2.3 High-throughput Sequencing
1.2.4 Nucleic Acid Detection Based on Real-time Fluorescent Quantitative PCR
1.2.5 Immunological Detection
1.3 Global COVID-19 Molecular Diagnostics Market by Application
1.3.1 Overview: Global COVID-19 Molecular Diagnostics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Scientific Research
1.3.4 Biodiagnostics
1.4 Global COVID-19 Molecular Diagnostics Market by Regions
1.4.1 Global COVID-19 Molecular Diagnostics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of COVID-19 Molecular Diagnostics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) COVID-19 Molecular Diagnostics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) COVID-19 Molecular Diagnostics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) COVID-19 Molecular Diagnostics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) COVID-19 Molecular Diagnostics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) COVID-19 Molecular Diagnostics Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: COVID-19 Molecular Diagnostics Industry Impact
1.5.1 COVID-19 Potential Implications for the COVID-19 Molecular Diagnostics
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on COVID-19 Molecular Diagnostics
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Cellex
2.1.1 Cellex Details
2.1.2 Cellex Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Cellex SWOT Analysis
2.1.4 Cellex Product and Services
2.1.5 Cellex COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.2 Thermo Fisher
2.2.1 Thermo Fisher Details
2.2.2 Thermo Fisher Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Thermo Fisher SWOT Analysis
2.2.4 Thermo Fisher Product and Services
2.2.5 Thermo Fisher COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.3 BioMedomics
2.3.1 BioMedomics Details
2.3.2 BioMedomics Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 BioMedomics SWOT Analysis
2.3.4 BioMedomics Product and Services
2.3.5 BioMedomics COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.4 Abbott
2.4.1 Abbott Details
2.4.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Abbott SWOT Analysis
2.4.4 Abbott Product and Services
2.4.5 Abbott COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Safecare Bio-Tech
2.5.1 Safecare Bio-Tech Details
2.5.2 Safecare Bio-Tech Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Safecare Bio-Tech SWOT Analysis
2.5.4 Safecare Bio-Tech Product and Services
2.5.5 Safecare Bio-Tech COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Roche
2.6.1 Roche Details
2.6.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Roche SWOT Analysis
2.6.4 Roche Product and Services
2.6.5 Roche COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.7 Agilent
2.7.1 Agilent Details
2.7.2 Agilent Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Agilent SWOT Analysis
2.7.4 Agilent Product and Services
2.7.5 Agilent COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.8 Henry Schein
2.8.1 Henry Schein Details
2.8.2 Henry Schein Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Henry Schein SWOT Analysis
2.8.4 Henry Schein Product and Services
2.8.5 Henry Schein COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.9 BD
2.9.1 BD Details
2.9.2 BD Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 BD SWOT Analysis
2.9.4 BD Product and Services
2.9.5 BD COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.10 Bio-rad
2.10.1 Bio-rad Details
2.10.2 Bio-rad Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Bio-rad SWOT Analysis
2.10.4 Bio-rad Product and Services
2.10.5 Bio-rad COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.11 Guangdong Hecin-Scientific
2.11.1 Guangdong Hecin-Scientific Details
2.11.2 Guangdong Hecin-Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Guangdong Hecin-Scientific SWOT Analysis
2.11.4 Guangdong Hecin-Scientific Product and Services
2.11.5 Guangdong Hecin-Scientific COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.12 Mayo Clinic Laboratories
2.12.1 Mayo Clinic Laboratories Details
2.12.2 Mayo Clinic Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Mayo Clinic Laboratories SWOT Analysis
2.12.4 Mayo Clinic Laboratories Product and Services
2.12.5 Mayo Clinic Laboratories COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.13 Ortho Clinical Diagnostics
2.13.1 Ortho Clinical Diagnostics Details
2.13.2 Ortho Clinical Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Ortho Clinical Diagnostics SWOT Analysis
2.13.4 Ortho Clinical Diagnostics Product and Services
2.13.5 Ortho Clinical Diagnostics COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.14 Mount Sinai Laboratory
2.14.1 Mount Sinai Laboratory Details
2.14.2 Mount Sinai Laboratory Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Mount Sinai Laboratory SWOT Analysis
2.14.4 Mount Sinai Laboratory Product and Services
2.14.5 Mount Sinai Laboratory COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.15 Dynamiker Biotechnology (Tianjin)
2.15.1 Dynamiker Biotechnology (Tianjin) Details
2.15.2 Dynamiker Biotechnology (Tianjin) Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Dynamiker Biotechnology (Tianjin) SWOT Analysis
2.15.4 Dynamiker Biotechnology (Tianjin) Product and Services
2.15.5 Dynamiker Biotechnology (Tianjin) COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.16 Guangzhou Wondfo Biotech
2.16.1 Guangzhou Wondfo Biotech Details
2.16.2 Guangzhou Wondfo Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Guangzhou Wondfo Biotech SWOT Analysis
2.16.4 Guangzhou Wondfo Biotech Product and Services
2.16.5 Guangzhou Wondfo Biotech COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.17 Zhejiang Orient Gene Biotech
2.17.1 Zhejiang Orient Gene Biotech Details
2.17.2 Zhejiang Orient Gene Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Zhejiang Orient Gene Biotech SWOT Analysis
2.17.4 Zhejiang Orient Gene Biotech Product and Services
2.17.5 Zhejiang Orient Gene Biotech COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.18 Chembio Diagnostics
2.18.1 Chembio Diagnostics Details
2.18.2 Chembio Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Chembio Diagnostics SWOT Analysis
2.18.4 Chembio Diagnostics Product and Services
2.18.3 Chembio Diagnostics COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.19 ADVAITE
2.19.1 ADVAITE Details
2.19.2 ADVAITE Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 ADVAITE SWOT Analysis
2.19.4 ADVAITE Product and Services
2.19.5 ADVAITE COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.20 Innovita Biological Technology
2.20.1 Innovita Biological Technology Details
2.20.2 Innovita Biological Technology Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 Innovita Biological Technology SWOT Analysis
2.20.4 Innovita Biological Technology Product and Services
2.20.5 Innovita Biological Technology COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.21 Da An Gene
2.21.1 Da An Gene Details
2.21.2 Da An Gene Major Business and Total Revenue (Financial Highlights) Analysis
2.21.3 Da An Gene SWOT Analysis
2.21.4 Da An Gene Product and Services
2.21.5 Da An Gene COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.22 QIAGEN
2.22.1 QIAGEN Details
2.22.2 QIAGEN Major Business and Total Revenue (Financial Highlights) Analysis
2.22.3 QIAGEN SWOT Analysis
2.22.4 QIAGEN Product and Services
2.22.5 QIAGEN COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.23 Techne
2.23.1 Techne Details
2.23.2 Techne Major Business and Total Revenue (Financial Highlights) Analysis
2.23.3 Techne SWOT Analysis
2.23.4 Techne Product and Services
2.23.5 Techne COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.24 Analytik Jena
2.24.1 Analytik Jena Details
2.24.2 Analytik Jena Major Business and Total Revenue (Financial Highlights) Analysis
2.24.3 Analytik Jena SWOT Analysis
2.24.4 Analytik Jena Product and Services
2.24.5 Analytik Jena COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.25 Shanghai ZJ Bio-Tech
2.25.1 Shanghai ZJ Bio-Tech Details
2.25.2 Shanghai ZJ Bio-Tech Major Business and Total Revenue (Financial Highlights) Analysis
2.25.3 Shanghai ZJ Bio-Tech SWOT Analysis
2.25.4 Shanghai ZJ Bio-Tech Product and Services
2.25.5 Shanghai ZJ Bio-Tech COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.26 Esco
2.26.1 Esco Details
2.26.2 Esco Major Business and Total Revenue (Financial Highlights) Analysis
2.26.3 Esco SWOT Analysis
2.26.4 Esco Product and Services
2.26.5 Esco COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.27 Bioer
2.27.1 Bioer Details
2.27.2 Bioer Major Business and Total Revenue (Financial Highlights) Analysis
2.27.3 Bioer SWOT Analysis
2.27.4 Bioer Product and Services
2.27.5 Bioer COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.28 BGI
2.28.1 BGI Details
2.28.2 BGI Major Business and Total Revenue (Financial Highlights) Analysis
2.28.3 BGI SWOT Analysis
2.28.4 BGI Product and Services
2.28.5 BGI COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.29 Biosynex
2.29.1 Biosynex Details
2.29.2 Biosynex Major Business and Total Revenue (Financial Highlights) Analysis
2.29.3 Biosynex SWOT Analysis
2.29.4 Biosynex Product and Services
2.29.5 Biosynex COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global COVID-19 Molecular Diagnostics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 COVID-19 Molecular Diagnostics Players Market Share
3.2.2 Top 10 COVID-19 Molecular Diagnostics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global COVID-19 Molecular Diagnostics Revenue and Market Share by Regions
4.2 North America COVID-19 Molecular Diagnostics Revenue and Growth Rate (2015-2020)
4.3 Europe COVID-19 Molecular Diagnostics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific COVID-19 Molecular Diagnostics Revenue and Growth Rate (2015-2020)
4.5 South America COVID-19 Molecular Diagnostics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa COVID-19 Molecular Diagnostics Revenue and Growth Rate (2015-2020)
5 North America COVID-19 Molecular Diagnostics Revenue by Countries
5.1 North America COVID-19 Molecular Diagnostics Revenue by Countries (2015-2020)
5.2 USA COVID-19 Molecular Diagnostics Revenue and Growth Rate (2015-2020)
5.3 Canada COVID-19 Molecular Diagnostics Revenue and Growth Rate (2015-2020)
5.4 Mexico COVID-19 Molecular Diagnostics Revenue and Growth Rate (2015-2020)
6 Europe COVID-19 Molecular Diagnostics Revenue by Countries
6.1 Europe COVID-19 Molecular Diagnostics Revenue by Countries (2015-2020)
6.2 Germany COVID-19 Molecular Diagnostics Revenue and Growth Rate (2015-2020)
6.3 UK COVID-19 Molecular Diagnostics Revenue and Growth Rate (2015-2020)
6.4 France COVID-19 Molecular Diagnostics Revenue and Growth Rate (2015-2020)
6.5 Russia COVID-19 Molecular Diagnostics Revenue and Growth Rate (2015-2020)
6.6 Italy COVID-19 Molecular Diagnostics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific COVID-19 Molecular Diagnostics Revenue by Countries
7.1 Asia-Pacific COVID-19 Molecular Diagnostics Revenue by Countries (2015-2020)
7.2 China COVID-19 Molecular Diagnostics Revenue and Growth Rate (2015-2020)
7.3 Japan COVID-19 Molecular Diagnostics Revenue and Growth Rate (2015-2020)
7.4 Korea COVID-19 Molecular Diagnostics Revenue and Growth Rate (2015-2020)
7.5 India COVID-19 Molecular Diagnostics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia COVID-19 Molecular Diagnostics Revenue and Growth Rate (2015-2020)
8 South America COVID-19 Molecular Diagnostics Revenue by Countries
8.1 South America COVID-19 Molecular Diagnostics Revenue by Countries (2015-2020)
8.2 Brazil COVID-19 Molecular Diagnostics Revenue and Growth Rate (2015-2020)
8.3 Argentina COVID-19 Molecular Diagnostics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue COVID-19 Molecular Diagnostics by Countries
9.1 Middle East & Africa COVID-19 Molecular Diagnostics Revenue by Countries (2015-2020)
9.2 Saudi Arabia COVID-19 Molecular Diagnostics Revenue and Growth Rate (2015-2020)
9.3 UAE COVID-19 Molecular Diagnostics Revenue and Growth Rate (2015-2020)
9.4 Egypt COVID-19 Molecular Diagnostics Revenue and Growth Rate (2015-2020)
9.5 South Africa COVID-19 Molecular Diagnostics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global COVID-19 Molecular Diagnostics Revenue and Market Share by Type (2015-2020)
10.2 Global COVID-19 Molecular Diagnostics Market Forecast by Type (2019-2024)
10.3 High-throughput Sequencing Revenue Growth Rate (2015-2025)
10.4 Nucleic Acid Detection Based on Real-time Fluorescent Quantitative PCR Revenue Growth Rate (2015-2025)
10.5 Immunological Detection Revenue Growth Rate (2015-2025)
11 Global COVID-19 Molecular Diagnostics Market Segment by Application
11.1 Global COVID-19 Molecular Diagnostics Revenue Market Share by Application (2015-2020)
11.2 COVID-19 Molecular Diagnostics Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Scientific Research Revenue Growth (2015-2020)
11.5 Biodiagnostics Revenue Growth (2015-2020)
12 Global COVID-19 Molecular Diagnostics Market Size Forecast (2021-2025)
12.1 Global COVID-19 Molecular Diagnostics Market Size Forecast (2021-2025)
12.2 Global COVID-19 Molecular Diagnostics Market Forecast by Regions (2021-2025)
12.3 North America COVID-19 Molecular Diagnostics Revenue Market Forecast (2021-2025)
12.4 Europe COVID-19 Molecular Diagnostics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific COVID-19 Molecular Diagnostics Revenue Market Forecast (2021-2025)
12.6 South America COVID-19 Molecular Diagnostics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa COVID-19 Molecular Diagnostics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
List of Tables
Table 1. Global COVID-19 Molecular Diagnostics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of COVID-19 Molecular Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global COVID-19 Molecular Diagnostics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market COVID-19 Molecular Diagnostics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global COVID-19 Molecular Diagnostics Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Cellex Corporate Information, Location and Competitors
Table 7. Cellex COVID-19 Molecular Diagnostics Major Business
Table 8. Cellex COVID-19 Molecular Diagnostics Total Revenue (USD Million) (2017-2018)
Table 9. Cellex SWOT Analysis
Table 10. Cellex COVID-19 Molecular Diagnostics Product and Solutions
Table 11. Cellex COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Thermo Fisher Corporate Information, Location and Competitors
Table 13. Thermo Fisher COVID-19 Molecular Diagnostics Major Business
Table 14. Thermo Fisher COVID-19 Molecular Diagnostics Total Revenue (USD Million) (2018-2019)
Table 15. Thermo Fisher SWOT Analysis
Table 16. Thermo Fisher COVID-19 Molecular Diagnostics Product and Solutions
Table 17. Thermo Fisher COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. BioMedomics Corporate Information, Location and Competitors
Table 19. BioMedomics COVID-19 Molecular Diagnostics Major Business
Table 20. BioMedomics COVID-19 Molecular Diagnostics Total Revenue (USD Million) (2017-2018)
Table 21. BioMedomics SWOT Analysis
Table 22. BioMedomics COVID-19 Molecular Diagnostics Product and Solutions
Table 23. BioMedomics COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Abbott Corporate Information, Location and Competitors
Table 25. Abbott COVID-19 Molecular Diagnostics Major Business
Table 26. Abbott COVID-19 Molecular Diagnostics Total Revenue (USD Million) (2017-2018)
Table 27. Abbott SWOT Analysis
Table 28. Abbott COVID-19 Molecular Diagnostics Product and Solutions
Table 29. Abbott COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Safecare Bio-Tech Corporate Information, Location and Competitors
Table 31. Safecare Bio-Tech COVID-19 Molecular Diagnostics Major Business
Table 32. Safecare Bio-Tech COVID-19 Molecular Diagnostics Total Revenue (USD Million) (2017-2018)
Table 33. Safecare Bio-Tech SWOT Analysis
Table 34. Safecare Bio-Tech COVID-19 Molecular Diagnostics Product and Solutions
Table 35. Safecare Bio-Tech COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Roche Corporate Information, Location and Competitors
Table 37. Roche COVID-19 Molecular Diagnostics Major Business
Table 38. Roche COVID-19 Molecular Diagnostics Total Revenue (USD Million) (2017-2018)
Table 39. Roche SWOT Analysis
Table 40. Roche COVID-19 Molecular Diagnostics Product and Solutions
Table 41. Roche COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Agilent Corporate Information, Location and Competitors
Table 43. Agilent COVID-19 Molecular Diagnostics Major Business
Table 44. Agilent COVID-19 Molecular Diagnostics Total Revenue (USD Million) (2017-2018)
Table 45. Agilent SWOT Analysis
Table 46. Agilent COVID-19 Molecular Diagnostics Product and Solutions
Table 47. Agilent COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Henry Schein Corporate Information, Location and Competitors
Table 49. Henry Schein COVID-19 Molecular Diagnostics Major Business
Table 50. Henry Schein COVID-19 Molecular Diagnostics Total Revenue (USD Million) (2017-2018)
Table 51. Henry Schein SWOT Analysis
Table 52. Henry Schein COVID-19 Molecular Diagnostics Product and Solutions
Table 53. Henry Schein COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. BD Corporate Information, Location and Competitors
Table 55. BD COVID-19 Molecular Diagnostics Major Business
Table 56. BD COVID-19 Molecular Diagnostics Total Revenue (USD Million) (2017-2018)
Table 57. BD SWOT Analysis
Table 58. BD COVID-19 Molecular Diagnostics Product and Solutions
Table 59. BD COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Bio-rad Corporate Information, Location and Competitors
Table 61. Bio-rad COVID-19 Molecular Diagnostics Major Business
Table 62. Bio-rad COVID-19 Molecular Diagnostics Total Revenue (USD Million) (2017-2018)
Table 63. Bio-rad SWOT Analysis
Table 64. Bio-rad COVID-19 Molecular Diagnostics Product and Solutions
Table 65. Bio-rad COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Guangdong Hecin-Scientific Corporate Information, Location and Competitors
Table 67. Guangdong Hecin-Scientific COVID-19 Molecular Diagnostics Major Business
Table 68. Guangdong Hecin-Scientific COVID-19 Molecular Diagnostics Total Revenue (USD Million) (2017-2018)
Table 69. Guangdong Hecin-Scientific SWOT Analysis
Table 70. Guangdong Hecin-Scientific COVID-19 Molecular Diagnostics Product and Solutions
Table 71. Guangdong Hecin-Scientific COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Mayo Clinic Laboratories Corporate Information, Location and Competitors
Table 73. Mayo Clinic Laboratories COVID-19 Molecular Diagnostics Major Business
Table 74. Mayo Clinic Laboratories COVID-19 Molecular Diagnostics Total Revenue (USD Million) (2017-2018)
Table 75. Mayo Clinic Laboratories SWOT Analysis
Table 76. Mayo Clinic Laboratories COVID-19 Molecular Diagnostics Product and Solutions
Table 77. Mayo Clinic Laboratories COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Ortho Clinical Diagnostics Corporate Information, Location and Competitors
Table 79. Ortho Clinical Diagnostics COVID-19 Molecular Diagnostics Major Business
Table 80. Ortho Clinical Diagnostics COVID-19 Molecular Diagnostics Total Revenue (USD Million) (2017-2018)
Table 81. Ortho Clinical Diagnostics SWOT Analysis
Table 82. Ortho Clinical Diagnostics COVID-19 Molecular Diagnostics Product and Solutions
Table 83. Ortho Clinical Diagnostics COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. Mount Sinai Laboratory Corporate Information, Location and Competitors
Table 85. Mount Sinai Laboratory COVID-19 Molecular Diagnostics Major Business
Table 86. Mount Sinai Laboratory COVID-19 Molecular Diagnostics Total Revenue (USD Million) (2017-2018)
Table 87. Mount Sinai Laboratory SWOT Analysis
Table 88. Mount Sinai Laboratory COVID-19 Molecular Diagnostics Product and Solutions
Table 89. Mount Sinai Laboratory COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. Dynamiker Biotechnology (Tianjin) Corporate Information, Location and Competitors
Table 91. Dynamiker Biotechnology (Tianjin) COVID-19 Molecular Diagnostics Major Business
Table 92. Dynamiker Biotechnology (Tianjin) COVID-19 Molecular Diagnostics Total Revenue (USD Million) (2017-2018)
Table 93. Dynamiker Biotechnology (Tianjin) SWOT Analysis
Table 94. Dynamiker Biotechnology (Tianjin) COVID-19 Molecular Diagnostics Product and Solutions
Table 95. Dynamiker Biotechnology (Tianjin) COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 96. Guangzhou Wondfo Biotech Corporate Information, Location and Competitors
Table 97. Guangzhou Wondfo Biotech COVID-19 Molecular Diagnostics Major Business
Table 98. Guangzhou Wondfo Biotech COVID-19 Molecular Diagnostics Total Revenue (USD Million) (2017-2018)
Table 99. Guangzhou Wondfo Biotech SWOT Analysis
Table 100. Guangzhou Wondfo Biotech COVID-19 Molecular Diagnostics Product and Solutions
Table 101. Guangzhou Wondfo Biotech COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 102. Zhejiang Orient Gene Biotech Corporate Information, Location and Competitors
Table 103. Zhejiang Orient Gene Biotech COVID-19 Molecular Diagnostics Major Business
Table 104. Zhejiang Orient Gene Biotech COVID-19 Molecular Diagnostics Total Revenue (USD Million) (2017-2018)
Table 105. Zhejiang Orient Gene Biotech SWOT Analysis
Table 106. Zhejiang Orient Gene Biotech COVID-19 Molecular Diagnostics Product and Solutions
Table 107. Zhejiang Orient Gene Biotech COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 108. Chembio Diagnostics COVID-19 Molecular Diagnostics Type and Application
Table 109. Chembio Diagnostics COVID-19 Molecular Diagnostics Major Business
Table 110. Chembio Diagnostics COVID-19 Molecular Diagnostics Total Revenue (USD Million) (2017-2018)
Table 111. Chembio Diagnostics SWOT Analysis
Table 112. Chembio Diagnostics COVID-19 Molecular Diagnostics Product and Solutions
Table 113. Chembio Diagnostics COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 114. ADVAITE Corporate Information, Location and Competitors
Table 115. ADVAITE COVID-19 Molecular Diagnostics Major Business
Table 116. ADVAITE COVID-19 Molecular Diagnostics Total Revenue (USD Million) (2017-2018)
Table 117. ADVAITE SWOT Analysis
Table 118. ADVAITE COVID-19 Molecular Diagnostics Product and Solutions
Table 119. ADVAITE COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 120. Innovita Biological Technology Corporate Information, Location and Competitors
Table 121. Innovita Biological Technology COVID-19 Molecular Diagnostics Major Business
Table 122. Innovita Biological Technology COVID-19 Molecular Diagnostics Total Revenue (USD Million) (2017-2018)
Table 123. Innovita Biological Technology SWOT Analysis
Table 124. Innovita Biological Technology COVID-19 Molecular Diagnostics Product and Solutions
Table 125. Innovita Biological Technology COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 126. Da An Gene Corporate Information, Location and Competitors
Table 127. Da An Gene COVID-19 Molecular Diagnostics Major Business
Table 128. Da An Gene COVID-19 Molecular Diagnostics Total Revenue (USD Million) (2017-2018)
Table 129. Da An Gene SWOT Analysis
Table 130. Da An Gene COVID-19 Molecular Diagnostics Product and Solutions
Table 131. Da An Gene COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 132. QIAGEN Corporate Information, Location and Competitors
Table 133. QIAGEN COVID-19 Molecular Diagnostics Major Business
Table 134. QIAGEN COVID-19 Molecular Diagnostics Total Revenue (USD Million) (2017-2018)
Table 135. QIAGEN SWOT Analysis
Table 136. QIAGEN COVID-19 Molecular Diagnostics Product and Solutions
Table 137. QIAGEN COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 138. Techne Corporate Information, Location and Competitors
Table 139. Techne COVID-19 Molecular Diagnostics Major Business
Table 140. Techne COVID-19 Molecular Diagnostics Total Revenue (USD Million) (2017-2018)
Table 141. Techne SWOT Analysis
Table 142. Techne COVID-19 Molecular Diagnostics Product and Solutions
Table 143. Techne COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 144. Analytik Jena Corporate Information, Location and Competitors
Table 145. Analytik Jena COVID-19 Molecular Diagnostics Major Business
Table 146. Analytik Jena COVID-19 Molecular Diagnostics Total Revenue (USD Million) (2017-2018)
Table 147. Analytik Jena SWOT Analysis
Table 148. Analytik Jena COVID-19 Molecular Diagnostics Product and Solutions
Table 149. Analytik Jena COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 150. Shanghai ZJ Bio-Tech Corporate Information, Location and Competitors
Table 151. Shanghai ZJ Bio-Tech COVID-19 Molecular Diagnostics Major Business
Table 152. Shanghai ZJ Bio-Tech COVID-19 Molecular Diagnostics Total Revenue (USD Million) (2017-2018)
Table 153. Shanghai ZJ Bio-Tech SWOT Analysis
Table 154. Shanghai ZJ Bio-Tech COVID-19 Molecular Diagnostics Product and Solutions
Table 155. Shanghai ZJ Bio-Tech COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 156. Esco Corporate Information, Location and Competitors
Table 157. Esco COVID-19 Molecular Diagnostics Major Business
Table 158. Esco COVID-19 Molecular Diagnostics Total Revenue (USD Million) (2017-2018)
Table 159. Esco SWOT Analysis
Table 160. Esco COVID-19 Molecular Diagnostics Product and Solutions
Table 161. Esco COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 162. Bioer Corporate Information, Location and Competitors
Table 163. Bioer COVID-19 Molecular Diagnostics Major Business
Table 164. Bioer COVID-19 Molecular Diagnostics Total Revenue (USD Million) (2017-2018)
Table 165. Bioer SWOT Analysis
Table 166. Bioer COVID-19 Molecular Diagnostics Product and Solutions
Table 167. Bioer COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 168. BGI Corporate Information, Location and Competitors
Table 169. BGI COVID-19 Molecular Diagnostics Major Business
Table 170. BGI COVID-19 Molecular Diagnostics Total Revenue (USD Million) (2017-2018)
Table 171. BGI SWOT Analysis
Table 172. BGI COVID-19 Molecular Diagnostics Product and Solutions
Table 173. BGI COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 174. Biosynex Corporate Information, Location and Competitors
Table 175. Biosynex COVID-19 Molecular Diagnostics Major Business
Table 176. Biosynex COVID-19 Molecular Diagnostics Total Revenue (USD Million) (2017-2018)
Table 177. Biosynex SWOT Analysis
Table 178. Biosynex COVID-19 Molecular Diagnostics Product and Solutions
Table 179. Biosynex COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 180. Global COVID-19 Molecular Diagnostics Revenue (Million USD) by Players (2015-2020)
Table 181. Global COVID-19 Molecular Diagnostics Revenue Share by Players (2015-2020)
Table 182. Global COVID-19 Molecular Diagnostics Revenue (Million USD) by Regions (2015-2020)
Table 183. Global COVID-19 Molecular Diagnostics Revenue Market Share by Regions (2015-2020)
Table 184. North America COVID-19 Molecular Diagnostics Revenue by Countries (2015-2020)
Table 185. North America COVID-19 Molecular Diagnostics Revenue Market Share by Countries (2015-2020)
Table 186. Europe COVID-19 Molecular Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 187. Asia-Pacific COVID-19 Molecular Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 188. South America COVID-19 Molecular Diagnostics Revenue by Countries (2015-2020)
Table 189. South America COVID-19 Molecular Diagnostics Revenue Market Share by Countries (2015-2020)
Table 190. Middle East and Africa COVID-19 Molecular Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 191. Middle East and Africa COVID-19 Molecular Diagnostics Revenue Market Share by Countries (2015-2020)
Table 192. Global COVID-19 Molecular Diagnostics Revenue (Million USD) by Type (2015-2020)
Table 193. Global COVID-19 Molecular Diagnostics Revenue Share by Type (2015-2020)
Table 194. Global COVID-19 Molecular Diagnostics Revenue Forecast by Type (2021-2025)
Table 195. Global COVID-19 Molecular Diagnostics Revenue by Application (2015-2020)
Table 196. Global COVID-19 Molecular Diagnostics Revenue Share by Application (2015-2020)
Table 197. Global COVID-19 Molecular Diagnostics Revenue Forecast by Application (2021-2025)
Table 198. Global COVID-19 Molecular Diagnostics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. COVID-19 Molecular Diagnostics Picture
Figure 2. Global COVID-19 Molecular Diagnostics Revenue Market Share by Type in 2019
Figure 3. High-throughput Sequencing Picture
Figure 4. Nucleic Acid Detection Based on Real-time Fluorescent Quantitative PCR Picture
Figure 5. Immunological Detection Picture
Figure 6. COVID-19 Molecular Diagnostics Revenue Market Share by Application in 2019
Figure 7. Hospitals Picture
Figure 8. Scientific Research Picture
Figure 9. Biodiagnostics Picture
Figure 10. Global COVID-19 Molecular Diagnostics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America COVID-19 Molecular Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe COVID-19 Molecular Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific COVID-19 Molecular Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America COVID-19 Molecular Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa COVID-19 Molecular Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global COVID-19 Molecular Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global COVID-19 Molecular Diagnostics Revenue Share by Players in 2019
Figure 18. Global Top 5 Players COVID-19 Molecular Diagnostics Revenue Market Share in 2019
Figure 19. Global Top 10 Players COVID-19 Molecular Diagnostics Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global COVID-19 Molecular Diagnostics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global COVID-19 Molecular Diagnostics Revenue Market Share by Regions (2015-2020)
Figure 23. Global COVID-19 Molecular Diagnostics Revenue Market Share by Regions in 2018
Figure 24. North America COVID-19 Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 25. Europe COVID-19 Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific COVID-19 Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 27. South America COVID-19 Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa COVID-19 Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 29. North America COVID-19 Molecular Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 30. North America COVID-19 Molecular Diagnostics Revenue Market Share by Countries in 2019
Figure 31. USA COVID-19 Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 32. Canada COVID-19 Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 33. Mexico COVID-19 Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 34. Europe COVID-19 Molecular Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 35. Europe COVID-19 Molecular Diagnostics Revenue Market Share by Countries in 2019
Figure 36. Germany COVID-19 Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 37. UK COVID-19 Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 38. France COVID-19 Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 39. Russia COVID-19 Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 40. Italy COVID-19 Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific COVID-19 Molecular Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific COVID-19 Molecular Diagnostics Revenue Market Share by Countries in 2019
Figure 43. China COVID-19 Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 44. Japan COVID-19 Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 45. Korea COVID-19 Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 46. India COVID-19 Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia COVID-19 Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 48. South America COVID-19 Molecular Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 49. South America COVID-19 Molecular Diagnostics Revenue Market Share by Countries in 2019
Figure 50. Brazil COVID-19 Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 51. Argentina COVID-19 Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa COVID-19 Molecular Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa COVID-19 Molecular Diagnostics Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia COVID-19 Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 55. UAE COVID-19 Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 56. Egypt COVID-19 Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 57. South Africa COVID-19 Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 58. Global COVID-19 Molecular Diagnostics Revenue Share by Type (2015-2020)
Figure 59. Global COVID-19 Molecular Diagnostics Revenue Share by Type in 2019
Figure 60. Global COVID-19 Molecular Diagnostics Market Share Forecast by Type (2021-2025)
Figure 61. Global High-throughput Sequencing Revenue Growth Rate (2015-2020)
Figure 62. Global Nucleic Acid Detection Based on Real-time Fluorescent Quantitative PCR Revenue Growth Rate (2015-2020)
Figure 63. Global Immunological Detection Revenue Growth Rate (2015-2020)
Figure 64. Global COVID-19 Molecular Diagnostics Revenue Share by Application (2015-2020)
Figure 65. Global COVID-19 Molecular Diagnostics Revenue Share by Application in 2019
Figure 66. Global COVID-19 Molecular Diagnostics Market Share Forecast by Application (2021-2025)
Figure 67. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 68. Global Scientific Research Revenue Growth Rate (2015-2020)
Figure 69. Global Biodiagnostics Revenue Growth Rate (2015-2020)
Figure 70. Global COVID-19 Molecular Diagnostics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global COVID-19 Molecular Diagnostics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global COVID-19 Molecular Diagnostics Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America COVID-19 Molecular Diagnostics Revenue Market Forecast (2021-2025)
Figure 74. Europe COVID-19 Molecular Diagnostics Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific COVID-19 Molecular Diagnostics Revenue Market Forecast (2021-2025)
Figure 76. South America COVID-19 Molecular Diagnostics Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa COVID-19 Molecular Diagnostics Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Please feel free to write an email to us or to use our electronic ticketing system.
